Egelrud T, Régnier M, Sondell B, Shroot B and Schmidt R: Expression of stratum corneum chymotryptic enzyme in reconstructed human epidermis and its suppression by retinoic acid. Acta Derm Venereol (Stockholm) 1993; 73: 181-184.

Linder J, Nolgård P, Näsman B, Bäck O, Uddhammar A, and Olsson T: Decreased peripheral glucocorticoid sensitivity in Alzheimer's disease. Gerontology 1993; 39: 200-206.

Sandström M, Hansson Mild K, Stenberg B, and Wall S: A survey of electric and magnetic fields among VDT operators in offices. IEEE Transactions on Electromagnetic Compatibility, vol 35, no 3, August 1993.

Stenberg B, Hansson Mild K, Sandström M, Sundell J, and Wall S. A prevalence study of the sick building syndrome (SBS) and facial skin symptoms in office workers. Indoor Air 1993, 3: 71-81.

Egelrud T, Olivecrona T: Läkarutbildningen i Umeå, Kvalitet viktigare än pedagogisk modell. Läkartidningen, vol 91, 1994, pp 2511-2512.

Gamborg Nielsen P, Hofer P-Å, Lagerholm B: The dominant form of hereditary palmoplantar keratoderma in the northernmost county of Sweden (Norrbotten). Dermatology 1994; 188:188-193.

Hansson J, Ringborg U, Lagerlöf B, Afzelius L-E, Augustsson I, Blomquist E, Boeryd B, Carlin E, Edström S, Eldh J, Hanner P, Hedenborg L, Hofer P-Å, Johansson H, Lindholm C, Malec E, Näslund L, Schnürer L B, Sköld S, Wersäll J: Elective lymph node dissection in stage I cutaneous malignant melanoma of the head and neck. A report from the Swedish Melanoma Study Group. Melanoma Research 1994, 4, pp 407-411.

Hansson L, Strömqvist M, Bäckman A, Wallbrandt P, Carlstein A, Egelrud T: Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. J. Biol. Chem. 1994;269: 19420-6.

Hofer P-Å, Egelrud T: Implantation av syntethår ej riskfri. Läkartidningen, vol. 91, nr 34, 1994, 2967-2968.

Lind L, Lundström A., Hofer P-Å, Holmgren G: The gene for diffuse palmoplantar keratoderma of the type found in northern Sweden is localized to chromosome 12q11-q13. Human Molecular Genetics, 1994, Vol. 3, No. 10, 1789-1793.

Lundström A, Serre G, Haftek M, Egelrud T: Evidence for a role of corneodesmosin, a protein which may serve to modify desmosomes during cornification, in stratum corneum cell cohesion and desquamation. Acta Dermatol Res 1994, 286:369-375.

Sondell B, Thornell L-E, Egelrud T: Stratum corneum chemyotryptic enzyme has a subcellular distribution compative with a role in desquamation.ESDR (European Society for Dermatological Research), 24th Annual Meeting, Vienna 1994.

Sondell B, Thornell L-E, Stigbrand T, and Egelrud T: Immunolocalization of stratum corneum chymotryptic enzyme in human skin and oral epithelium with monoclonal antibodies: evidence of a proteinase specifically expressed in keratinizing squamous epithelia. The Journal of Histochemistry and Cytochemistry,Vol 42, No 4, pp 459-465, 1994.

Stenberg B: Office illness. The Worker, the Work and the Workplace. Umeå University Medical Dissertations. New Series No 399-ISSN 0346-6612. Umeå, 1994.

Stenberg B, Eriksson N, Höög J, Sundell J, Wall S: The sick building syndrome (SBS) in office workers. A case referent study of personal, psychosocial and building-related risk indicators. Int J Epidemiol 1994;23:1190-1197.

Stenberg B, Wall S: Why do women report "sick building symptoms" more than men? Soc Sci Med 1994;40:491-502.

Sundell J, Lindvall T, Stenberg B: Associations between type of ventilation and air flow rates in office buildings and the risk of SBS-symptoms among occupants. Environ Int 1994;20:239-51.

Sundell J, Lindvall T, Stenberg B, Wall S: Sick building syndrome (SBS) in office worker and facial skin symtoms among VDT-workers in relation to building and room characteristics. Two case-referent studies. Indoor Air, 1994;4:83-94.

Bäck O, Nilsson T. K: Retinoids and fibrinolysis. Acta Derm Venerol (Stockh) 1995; 75: 290-292.

Bäck O, Scheynius A, Johansson S G O: Ketoconazole in atopic dermatitis: therapeutic response is correlated with descrease in serum IgE. Arch Dermatol Res 1995, 287:448-451.

Egelrud T: Ny kunskap om hudens hornlager kan öka förståelsen av hudsjukdomar. Nordisk Medicin, vol 110, 3/1995.

Skytt Å, Strömqvist M, and Egelrud T: Primary subtrate specificity of recombinant human stratum corneum chymotryptic enzyme. Biochemical and Biophysical Research Communications 211, 586-589, 1995.

Sondell B, Thornell L-E, and Egerlud T: Evidence that stratum corneum chymotryptic enzyme is transported to the stratum corneum extrracellular space Via Lamellar Bodies. J Invest Dermatol 104:819-823, 1995.

Stenberg B: Skin symtoms and VDT work - Report from three continents. Work with display units94. A Grieco, G Molteni, B Piccoli and E Occhipinti (Editors). 1995 Elsevier Science B. V. All right reserved.

Egelrud T, Lundström A, Sondell B: Stratum corneum cell cohesion and desquamation in maintenance of the skin barrier. Dermatotoxicology, 1996.

Eriksson N, Höög J, Stenberg B, Sundell J: Psychosocial factors and the "Sick Building-Syndrome". A case-referent study. Indoor Air 1996; 6: 101-110.

Magnusson B M, and Koskinen L-O: Effects of topical application of capsaicin to human skin: A comparison of effects evaluated by visual assessment, sensation registration, skin blood flow and cutaneous impedance measurements. Acta Derm Venereol 1996; 76:129-132.

Nylander Lundqvist E, Bäck O, Egelrud T: IL-1 beta activation in human epidermis. The Journal of Immunology, 1996, 157: 1699-1704.

Sondell B, Dyberg P, Anneroth G KB, Östman P-O, Egelrud T: Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa. Acta Derm Venereol (Stockh) 1996; 76: 177-181.

Eriksson N, Höög J, Hansson Mild K, Sandström M, Stenberg B: The psychosocial work environment and skin symptoms among visual display terminal workers. A case referent study. Int J Epidemiol 1997; 26: 1250-57.

Eriksson N, Höög J, Sandström M, Stenberg B: Facial skin symptoms in office workers. A five-year follow-up study. JOEM 1997 39:108-18.

Magnusson B M, Runn P, Karlsson K, and Koskinen L-O: Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis. Int J Pharm 1997; 157:113-121.

Magnusson B M, Runn P, and Koskinen L-O: Enhancement by terpenes of transdermal permeation of water and ethanol in human epidermis. Acta Derm Venereol 1997; 77:264-267.

Nylander Lundqvist E, and Egelrud T: Biologically active, alternatively processed interleukin-1beta in psoriatic scales. Eur. J. Immunol. 1997;27:2165-2171.

Nylander Lundqvist E, Egelrud T: Formation of acive IL-1beta from Pro-IL-1beta catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm Venereol (Stockh) 1997;77:203-206.

Nylander Lundqvist E, Hofer P-Å, Olofsson J, Sjöberg I: Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women. Acta Derm Venereol (Stockh) 1997;77:319-322.

Sjöberg I, Nylander Lundqvist E: Vulvar vestibulitis in the north of Sweden. An epidemiologic case-control study. The Journal of Reproductive Medicine 1997;42, 3:166-168.

Sondell B, Jonsson M, Egelrud T: In situ evidence that the population of Langerhans cells in normal human epidermis may be heterogeneous. British Journal of Dermatology 1997; 136:687-693.

Brattsand B, and Egelrud, T: Purification and characterization of interleukin 1b from human plantar stratum corneum. Evidence of interleukin 1b processing in vivo not involving interleukin 1b convertase. Cytokine, 1998;10:506-603.

Egelrud T: Stratum corneum chymotryptic enzyme. Ur boken "Handbook of protolytic enzymes", Barret, Neil, Ranlings & Woersner (eds.), Academic Press, London 1998.

Ekholm E, and Egelrud T: The expression of stratum corneum chymotryptic enzyme in human anagen hair follicles: further evidence for its involvement in desquamation-like processes. British Journal of Dermatology 1998;139: 585-590.

Ekholm E, Sondell B, Strandén P, Brattsand M, and Egelrud T: Expression of stratum corneum chymotryptic enzyme in human sebaceous follicles. Acta Derm Venereol (Stockh) 1998; 78:343-347.

Nylander Lundqvist E, Companjen Arjen R, Prens Errol P, and Egelrud T: Biological activity of human epidermal interleukin-1beta: comparison with recombinant human interleukin-1beta. Eur Cytokine Netw 1998; 9:41-6.

Vicanová J, Boelsma E, Mommaas A M, Kempenaar J A, Forslind B, Pallon J, Egelrud T, Koerten H K, and Ponec M: Normalization of epidermal calsium distribution profile in reconstructed human epidermis is related to improvement of terminal differentiation and stratum corneum barrier formation. J Invest Dermatol 111:97-106, 1998.

Brattsand M, and Egelrud T: Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biological Chemistry 1999, 274:42, pp 30033-30040.

Bäckman A, Strandén P, Brattsand M, Hansson L, and Egelrud, T: Molecular cloning and tissue expression of the murine analog to human stratum corneum chymotryptic enzyme. J. Invest Dermatol 1999, 113:152-155.

Ekholm E, Egelrud T: Expression of stratum corneum chymotryptic enzyme in relation to other markers of epidermal differentiation in a skin explant model. Experimental Dermatology 1999, 9:65-70.

Ekholm E, Egelrud T: Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res 1999, 291:195-200.

Glas B, Egelrud T: Nickel in "nickel-free" spectacle frames. Contact Dermatitis 1999, 40:217.

Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Johannesson A, Berne B, Ljunggren B, Andersson T, Molin L, NylanderLundqvist E, Emtestam L: PUVA  and cancer risk: the Swedish follow-up study. Br J Dermatol 1999, Jul; 141(1):108:12.

Magnusson B M, and Runn P: Effect of penetration enhancers on the permeation of the thyrotropin releasing hormone analogue pGlu-3-methyl-His-Pro amide through human epidermis. Int J Pharm 1999; 178:149-159.

Stenberg B, Liden C: Elkänslighet och bildskärmsbesvär kräver seriös handläggning. Läkartidningen 1999, Dec 1;96(48):5377-9.

Diamandis EP, Yousef GM, Clements J, Ashworth LK, Yoshida S, Egelrud T, Nelson PS, Shiosaka S, Little S, Lilja H, Stenman UH, Rittenhouse HG, Wain H: New nomenclature for the human tissue kallikrein gene family. Clin Chem 2000, 46:1855-1858.

Egelrud T: Desquamation in the stratum corneum. Acta Derm Venereol 2000; Supp 208:1-2, pp 44-45.

Egelrud T: Quantification: the soft underbelly of molecular biology. Acta Derm Venereol 2000, 80:1.

Egelrud T, Vahlquist A: Hopp om nya terapier för svåra genetiska hudsjukdomar. Läkartidningen 2000, 97:4722-4726.

Ekholm E, Egelrud T: Expression of stratum corneum chymotryptic enzyme in relation to other markers of epidermal differentiation in a skin explant model. Experimental Dermatology 2000, 9:65-70.

Ekholm IE, Brattsand M, Egelrud T: Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 2000, 114:56-63.

Karlsson P, Stenberg B, Rosdahl I: Prevalence of pigmented naevi in a Swedish population living close to the Arctic Circle. Acta Derm Venereol 2000; 80:335-339.

Magnusson B.M, and Koskinen L-O: In vitro percutaneous penetration of topical application of capsaicin and in vivo sensation responses. Int J Pharm 2000, 195:55-62.

Simon M, Jonca N, Guerrin M, Haftek M, Bernard D, Caubet C, Egelrud T, Schmidt R, Serre G: Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 2001 Jun 8; 276(23):20292-9.

Hansson L, Bäckman A, Ny A, Edlund M, Ekholm E, Ekstrand Hammarström B, Törnell J, Wallbrandt P, Wennbo H, Egelrud T: Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol 2002; 118(3):444-449.

Stenberg B, Bergdahl J, Edvardsson B, Eriksson N, Lindén G, Widman L: Medical and social prognosis for patients with perceived hypersensitivity to electricity and skin symptoms related to the use of visual display terminals. Scand J Work Environ Health 2002; 28(5): 349-357.

Svensson Å, Lindberg M, Meding B, Sundberg K, Stenberg B: Epidemiology and Health Services Research. Self-reported hand eczema: symptom-based reports do not increase the validity of diagnosis. British Journal of Dermatology 2002; 147:281-284.

Wahlberg J E, Tammela M, Anderson C, Björkner B, Bruze M, Fischer T, Inerot A, Karlberg A-T, Lidén C, Lindberg M, Meding B, Möller H, Stenberg B, Sundberg K: Contact Allergy to p-Phenylenediamine in Sweden. Dermatol. Beruf Umwelt / Occup. Environ. Dermatol. 2002; 50(2): 51-54.

Lodén M, Andersson A-C, Anderson C, Bergbrant I-M, Frödin T, Öhman H, Sandström M-H, Särnhult T, Voog E, Stenberg B, Pawlik E, Preisler-Häggqvist A, Svensson Å, Lindberg M: A Double-Blind Study Comparing the Effect of Glycerin and Urea on Dry, Eczematous Skin in Atopic Patients. Acta Derm. Venerol. 2002; 82: 45-47.

Alenius G-M, Stenberg B, Stenlund H, Lundblad M, Rantapää Dahlqvist S: Inflammatory Joint Manifestations are Prevalent in Psoriasis: Prevalence Study of Joint and Axial Involvement in Psoriatic Patients, and Evaluation of a Psoriatic and Arthritic Questionnaire. The Journal of Rheumatology 2002, 29(12):2577-2582.

Hansson L, Bergman A, Ny A, Ekholm E, Egelrud T: Epidermal Overexpression of Stratum Corneum Chymotryptic Enzyme, Skin Inflammation, and Itch. IFSCC Magazine 2002, 5(4):279-283.

Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA: Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 2003 May;9(5):1710-1720.

Hensen P, Asadullah K, Windemuth C, Ruschendorf F, Huffmeier U, Staender M, Schmitt-Egenolf M, Wienker TF, Reis A, Traupe H: Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis. Br J Dermatol 2003;149:381-385.

Hensen P, Windemuth C, Huffmeier U, Ruschendorf F, Stadelmann A, Hoppe V, Fenneker D, Staender M, Schmitt-Egenolf M, Wienker TF, Traupe H, Reis A: Association scan of the novel psoriasis susceptibility region on chromosome 19:evidence for both susceptible and protective loci. Exp Dermatol 2003;2:490-496.

Ny A, Egelrud T: Transgenic mice over-expressing a serine protease in the skin: evidence of interferon gamma-independent MHC II expression by epidermal keratinocytes. Acta Derm Venereol 2003;83(5):322-327.

Sandström M, Lyskov E, Hörnsten R, Hansson Mild K, Wiklund U, Rask P, Klucharev V, Stenberg B, Bjerle P: Holter ECG monitoring in patients with perceived electrical hypersensitivity. Int J Psychophysiol 2003;49:227-235.

Stenberg B, Nyberg E, NylanderLundqvist E, Svensson Å, Meding B: Kartläggning visar brister i befolkningsstudier. Frågor om allergi och överkänslighet i huden bör samordnas och bli entydiga. Läkartidningen 2003; 100(4):213-217.

Bergdahl J, Stenberg B, Eriksson N, Lindén G, Widman L: Coping and self-image in patients with VDT-related skin symptoms and perceived hypersensitivity to electricity. Int Arch Occup Environ Health 2004;77:538-542.

Blomquist K:son H, Frängsmyr A, Hernell O, Stenberg B, Bäck O: Dietary intake of vitamin D during the second half of infancy in Swedish infants. Scand J Nutrition 2004;48(4):173-177.

Caubet C, Jonca N, Brattsand M, Guerrin M, Bernard D, Schmidt R, Egelrud T, Simon M, Serre G: Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004 May;122(5):1235-1244.

Glas B, Levin JO, Stenberg B, Stenlund H, Sunesson AL: Variability of personal chemical exposure in eight office buildings in Sweden. J Expo Anal Environ Epidemiol 2004;14 Suppl 1:S49-57.

Ny A, Egelrud T: Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme. Acta Derm Venereol 2004;84(1):18-22.

Pommer L, Fick J, Andersson B, Sundell J, Nilsson C, Sjöström M, Stenberg B: Separation of healthy and sick buildings in the Swedish office illness study by principal component analysis. Indoor Air 2004;14:16-23.

Schmitt-Egenolf M: PsoReg - the quality register for systemic psoriasis treatment. Forum for Nord Derm Ven 2004;9 November:104-107.

Uttjek M, Dufaker M, Nygren L, Stenberg B: Determinants of quality of life in a psoriasis population in northern Sweden. Acta Derm Venereol 2004;84(1):37-43.

Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T: A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005;124:198-203.

Egelrud T, Brattsand M, Kreutzmann P, Walden M, Vitzithum K, Marx UC, Forssmann WG, Magert HJ: hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J Dermatol 2005;Dec;153(6):1200-1203.

Karlsson Blomquist H, Frängsmyr A, Hernell O, Stenberg B, Bäck O: Dietary intake of vitamin D during the second half of infancy in Swedish infants. Scand J Nutr 2004;48:173-177.

Nyrén M, Lindberg M, Stenberg B, Svensson M, Svensson Å, Meding B: Influence of childhood atopic dermatitis on future worklife. Scand J Work Environ Health 2005;31 (6):474-478.

Tillberg A, Berglund A, Mårell L, Bergdahl J, Eriksson N, Lindén G, Stenberg B, Widman L: Changes in health over time in patients with symptoms allegedly caused by their dental restorative materials. Community Dent Oral Epidemiol 2005;33;427-437.

Uttjek M, Dufåker M, Nygren L, Stenberg B: Psoriasis care consumption and expectations from a gender perspective in a psoriasis population in Northern Sweden. Acta Derm Venereol 2005;85:503-508.

Stenberg B, Lindberg M, Meding B, Svensson Å: Is the question "Have you had childhood eczema?" useful for assessing childhood atopic eczema in adult population surveys? Contact Dermatitis 2006;54:334-337.